Aura Biosciences, Inc.AURANASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank86
5Y CAGR-43.0%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
-43.0%/yr
Long-term compound
Percentile
P86
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 2.47% |
| Q2 2025 | 1.45% |
| Q1 2025 | -4.42% |
| Q4 2024 | -19.69% |
| Q3 2024 | -2.06% |
| Q2 2024 | -2.01% |
| Q1 2024 | 9.97% |
| Q4 2023 | -20.96% |
| Q3 2023 | -1.05% |
| Q2 2023 | -4.28% |
| Q1 2023 | -10.40% |
| Q4 2022 | -9.70% |
| Q3 2022 | -16.21% |
| Q2 2022 | -7.84% |
| Q1 2022 | -10.18% |
| Q4 2021 | -30.71% |
| Q3 2021 | -1.07% |
| Q2 2021 | -48.49% |
| Q1 2021 | -20.74% |
| Q4 2020 | -35.20% |
| Q3 2020 | 41.01% |
| Q2 2020 | 18.05% |
| Q1 2020 | 0.00% |